Neuroinflammation in Alzheimer's disease: different molecular targets and potential therapeutic agents including curcumin.
about
Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st centuryCurcumin and Apigenin - novel and promising therapeutics against chronic neuroinflammation in Alzheimer's diseaseThe role of iron-induced fibrin in the pathogenesis of Alzheimer's disease and the protective role of magnesiumBrain insulin resistance and deficiency as therapeutic targets in Alzheimer's diseaseRivastigmine lowers Aβ and increases sAPPα levels, which parallel elevated synaptic markers and metabolic activity in degenerating primary rat neuronsCurcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma.Functional characterization of a competitive peptide antagonist of p65 in human macrophage-like cells suggests therapeutic potential for chronic inflammation.Anti-inflammatory Activity of 1-docosanoyl Cafferate Isolated from Rhus verniciflua in LPS-stimulated BV2 Microglial CellsInduction of an inflammatory loop by interleukin-1β and tumor necrosis factor-α involves NF-kB and STAT-1 in differentiated human neuroprogenitor cells.Methyl salicylate 2-O-β-D-lactoside, a novel salicylic acid analogue, acts as an anti-inflammatory agent on microglia and astrocytes.Curcumin is a potent modulator of microglial gene expression and migration.Elevated CSF levels of TACE activity and soluble TNF receptors in subjects with mild cognitive impairment and patients with Alzheimer's diseaseMitochondrial therapeutics in Alzheimer's disease and Parkinson's diseaseNeuroprotective and neurorescue effects of a novel polymeric nanoparticle formulation of curcumin (NanoCurc™) in the neuronal cell culture and animal model: implications for Alzheimer's disease.Regulation of cyclic AMP response element-binding protein during neuroglial interactions.3,4,5-Trihydroxycinnamic Acid Inhibits LPS-Induced iNOS Expression by Suppressing NF-κB Activation in BV2 Microglial CellsMemantine treatment decreases levels of secreted Alzheimer's amyloid precursor protein (APP) and amyloid beta (A beta) peptide in the human neuroblastoma cellsOxidative insults to neurons and synapse are prevented by aged garlic extract and S-allyl-L-cysteine treatment in the neuronal culture and APP-Tg mouse modelCurcumin exerts anti-inflammatory and antioxidative properties in 1-methyl-4-phenylpyridinium ion (MPP(+))-stimulated mesencephalic astrocytes by interference with TLR4 and downstream signaling pathwayBiochemical studies in Normal Pressure Hydrocephalus (NPH) patients: change in CSF levels of amyloid precursor protein (APP), amyloid-beta (Aβ) peptide and phospho-tauThe "aged garlic extract:" (AGE) and one of its active ingredients S-allyl-L-cysteine (SAC) as potential preventive and therapeutic agents for Alzheimer's disease (AD).Oxidant/Antioxidant imbalance and the risk of Alzheimer's diseasePolyphenols and human health: a prospectus.Review: unchained maladie - a reassessment of the role of Ubb(+1) -capped polyubiquitin chains in Alzheimer's disease.Curcumin and neurodegenerative diseases: a perspective.Anti-neuroinflammatory agents for the treatment of Alzheimer's disease.Insights into direct nose to brain delivery: current status and future perspective.Intranasal therapeutic strategies for management of Alzheimer's disease.Multi-Target Directed Drugs: A Modern Approach for Design of New Drugs for the treatment of Alzheimer's Disease.Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.Clinical development of curcumin in neurodegenerative disease.AAV serotype 2/1-mediated gene delivery of anti-inflammatory interleukin-10 enhances neurogenesis and cognitive function in APP+PS1 mice.Plants-Derived Neuroprotective Agents: Cutting the Cycle of Cell Death through Multiple MechanismsComparative Neuroprotective Effects of Dietary Curcumin and Solid Lipid Curcumin Particles in Cultured Mouse Neuroblastoma Cells after Exposure to Aβ42Investigations of curcumin and resveratrol on neurite outgrowth: perspectives on spinal muscular atrophy.Effect of curcumin on cisplatin- and oxaliplatin-induced oxidative stress in human embryonic kidney (HEK) 293 cells.A comparative study of dietary curcumin, nanocurcumin, and other classical amyloid-binding dyes for labeling and imaging of amyloid plaques in brain tissue of 5×-familial Alzheimer's disease mice.Nucleic Acid-Based Theranostics for Tackling Alzheimer's Disease.Solid lipid curcumin particles provide greater anti-amyloid, anti-inflammatory and neuroprotective effects than curcumin in the 5xFAD mouse model of Alzheimer's disease.Enhanced Cognitive Effects of Demethoxycurcumin, a Natural Derivative of Curcumin on Scopolamine-Induced Memory Impairment in Mice.
P2860
Q24630927-9784AD26-DE08-4781-A027-1C32276DCBE4Q26781090-4F462FF4-4BEF-4A98-A022-1F126954A969Q26859190-1001DD1B-A0CE-4883-82B5-CFCCB1AA148BQ28259585-1C2A8EB0-81C7-40C7-BE93-35DBCFF2D193Q28479242-EDD906F0-C26F-40E9-8031-7BF58415E149Q34163076-D00C490C-E57D-41EA-A222-5F3A47CB0439Q34672342-6BFEE895-51A0-482C-97D6-18D4CCA62490Q34706174-86901718-BAF9-4737-8966-6779FEE8A380Q34903095-594FE1C1-4DFE-4711-9E6A-D8098DB9423EQ35206182-289DE549-AF79-473F-9D98-F7CF9C5B0613Q35338546-8E481912-3127-438D-918A-99C20D0B6304Q35505131-6FF249F1-26A2-48F5-A992-15A79DC7DA17Q35579334-FA9F6BFB-7389-437B-A237-D6002A6B471DQ35828603-04727958-19BF-430E-B871-CCB2B79350ADQ35871299-32805545-34E3-4688-86EB-D6D508E6833DQ35919804-0D3A1242-A6F9-44C8-AE97-196C6F76B640Q36047013-22B4D82D-6BCB-4D48-BD02-BCE9B295F2B6Q36081625-399F1B7F-4EB4-4D1B-A2A2-FC430C66D5E1Q37004610-D1F15695-8286-4833-8B25-10173ABF0C89Q37269006-ED155807-BC78-42DC-B9A6-579D09D25409Q37615989-FFF1B7BA-B640-4593-B3EC-C8AD444DBB37Q37741560-A3DAD315-CA61-464A-BACB-EC31A4A6CB59Q37934984-11B0E943-3FBC-447A-899A-AD7629DB0DA8Q37955915-E74DEBFB-6DDB-463F-A092-09630F61BA6EQ38016212-01BE51FB-FF9D-4377-BC66-8345EA1EE76EQ38136313-605BB021-2B71-40C3-850B-8E82BBE3D154Q38150429-B9C170A7-0D8F-4D9C-8BAA-284E8573CD8EQ38176935-F99B3920-6A0C-4C59-8F13-0A78A4729AD1Q38213710-0D625D26-79FD-4F9B-A07C-B8CC4E4BDFEFQ38344541-12F54357-FE83-4CB1-96AF-72EA8EAB4E0AQ38513024-970DB5A9-EBE2-4AF5-AAC9-4EBDD592C5BEQ39893541-F819021B-39C9-4933-AAD2-53150DE42B62Q41622472-3C02FC29-E1CE-4720-8374-82F2BD8CBECEQ41785626-60E4DD3A-7E68-4A9C-A61E-BCF676494724Q41917612-385BAF06-1D95-4B92-97B5-37F424650EA8Q42740245-50E78766-EA00-4BAA-A232-ACCFEA162537Q48469277-2955D94D-6A8A-414D-8E75-2A9DD07F1D66Q50130748-01FEB1DB-BA68-4D89-A266-059DD352025AQ50321909-119A7A7C-6C4B-4C43-A589-800F47764A4DQ50492452-7B8F0CB0-47DC-420F-AD71-A8D649F9ED94
P2860
Neuroinflammation in Alzheimer's disease: different molecular targets and potential therapeutic agents including curcumin.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Neuroinflammation in Alzheimer ...... tic agents including curcumin.
@en
Neuroinflammation in Alzheimer ...... tic agents including curcumin.
@nl
type
label
Neuroinflammation in Alzheimer ...... tic agents including curcumin.
@en
Neuroinflammation in Alzheimer ...... tic agents including curcumin.
@nl
prefLabel
Neuroinflammation in Alzheimer ...... tic agents including curcumin.
@en
Neuroinflammation in Alzheimer ...... tic agents including curcumin.
@nl
P921
P1476
Neuroinflammation in Alzheimer ...... tic agents including curcumin.
@en
P2093
Balmiki Ray
Debomoy K Lahiri
P304
P356
10.1016/J.COPH.2009.06.012
P577
2009-08-03T00:00:00Z